Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.86372 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - NYSE:AQNB - US0158578080

25.85 USD
-0.02 (-0.08%)
Last: 9/12/2025, 8:04:00 PM
Fundamental Rating

3

AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 25 industry peers in the Multi-Utilities industry. AQNB has a bad profitability rating. Also its financial health evaluation is rather negative. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AQNB reported negative net income in multiple years.
Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -10.09%, AQNB is not doing good in the industry: 96.00% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -29.51%, AQNB is doing worse than 96.00% of the companies in the same industry.
The Return On Invested Capital of AQNB (3.00%) is worse than 88.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AQNB is in line with the industry average of 3.82%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.00%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -10.09%
ROE -29.51%
ROIC 3%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

With a Operating Margin value of 20.38%, AQNB perfoms like the industry average, outperforming 52.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AQNB has declined.
With a decent Gross Margin value of 74.06%, AQNB is doing good in the industry, outperforming 72.00% of the companies in the same industry.
AQNB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 20.38%
PM (TTM) N/A
GM 74.06%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AQNB is destroying value.
Compared to 1 year ago, AQNB has more shares outstanding
Compared to 5 years ago, AQNB has more shares outstanding
Compared to 1 year ago, AQNB has an improved debt to assets ratio.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

AQNB has an Altman-Z score of 1.32. This is a bad value and indicates that AQNB is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.32, AQNB belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
A Debt/Equity ratio of 1.29 is on the high side and indicates that AQNB has dependencies on debt financing.
The Debt to Equity ratio of AQNB (1.29) is better than 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Altman-Z 1.32
ROIC/WACC0.42
WACC7.12%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.09 indicates that AQNB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, AQNB belongs to the top of the industry, outperforming 88.00% of the companies in the same industry.
AQNB has a Quick Ratio of 1.09. This is a bad value and indicates that AQNB is not financially healthy enough and could expect problems in meeting its short term obligations.
AQNB has a Quick ratio of 0.90. This is amongst the best in the industry. AQNB outperforms 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.9
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -36.00% in the last year.
Measured over the past years, AQNB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.38% on average per year.
Looking at the last year, AQNB shows a very negative growth in Revenue. The Revenue has decreased by -25.45% in the last year.
The Revenue has been growing slightly by 7.38% on average over the past years.
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%

3.2 Future

The Earnings Per Share is expected to grow by 6.99% on average over the next years.
AQNB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.30% yearly.
EPS Next Y-15.38%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
EPS Next 5Y6.99%
Revenue Next Year-11.47%
Revenue Next 2Y-4.22%
Revenue Next 3Y-1.09%
Revenue Next 5Y2.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 80.78 indicates a quite expensive valuation of AQNB.
AQNB's Price/Earnings ratio is rather expensive when compared to the industry. AQNB is more expensive than 92.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (27.30), we can say AQNB is valued expensively.
The Price/Forward Earnings ratio is 70.77, which means the current valuation is very expensive for AQNB.
96.00% of the companies in the same industry are cheaper than AQNB, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of AQNB to the average of the S&P500 Index (22.73), we can say AQNB is valued expensively.
Industry RankSector Rank
PE 80.78
Fwd PE 70.77
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

AQNB's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. AQNB is more expensive than 96.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 29.14
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.64%
EPS Next 3Y5.49%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.72%, AQNB is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.16, AQNB pays a bit more dividend than its industry peers.
AQNB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 4.72%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
AQNB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-17.76%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

25.85

-0.02 (-0.08%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners72.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.85B
Analysts52.86
Price Target22.5 (-12.96%)
Short Float %0%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield 4.72%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-17.76%
Div Incr Years1
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.5475)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.74%
Min EPS beat(2)-0.69%
Max EPS beat(2)42.17%
EPS beat(4)1
Avg EPS beat(4)0.15%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)3
Avg EPS beat(8)0.22%
EPS beat(12)4
Avg EPS beat(12)-3.83%
EPS beat(16)5
Avg EPS beat(16)-3.04%
Revenue beat(2)2
Avg Revenue beat(2)3.06%
Min Revenue beat(2)0.82%
Max Revenue beat(2)5.31%
Revenue beat(4)2
Avg Revenue beat(4)0.36%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.11%
Revenue beat(12)7
Avg Revenue beat(12)0.07%
Revenue beat(16)10
Avg Revenue beat(16)1.41%
PT rev (1m)1.83%
PT rev (3m)5.92%
EPS NQ rev (1m)-2.48%
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.98%
EPS NY rev (3m)5.98%
Revenue NQ rev (1m)1.51%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.1%
Revenue NY rev (3m)-1.86%
Valuation
Industry RankSector Rank
PE 80.78
Fwd PE 70.77
P/S 8.35
P/FCF N/A
P/OCF 45
P/B 4.24
P/tB 6.03
EV/EBITDA 29.14
EPS(TTM)0.32
EY1.24%
EPS(NY)0.37
Fwd EY1.41%
FCF(TTM)-0.55
FCFYN/A
OCF(TTM)0.57
OCFY2.22%
SpS3.1
BVpS6.1
TBVpS4.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.09%
ROE -29.51%
ROCE 3.8%
ROIC 3%
ROICexc 3.01%
ROICexgc 3.38%
OM 20.38%
PM (TTM) N/A
GM 74.06%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexcg growth 3Y4.3%
ROICexcg growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.29
Debt/FCF N/A
Debt/EBITDA 6.71
Cap/Depr 209.43%
Cap/Sales 36.33%
Interest Coverage 1.25
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.9
Altman-Z 1.32
F-Score4
WACC7.12%
ROIC/WACC0.42
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%-55.56%
EPS Next Y-15.38%
EPS Next 2Y-0.64%
EPS Next 3Y5.49%
EPS Next 5Y6.99%
Revenue 1Y (TTM)-25.45%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%-11.83%
Revenue Next Year-11.47%
Revenue Next 2Y-4.22%
Revenue Next 3Y-1.09%
Revenue Next 5Y2.3%
EBIT growth 1Y-22.44%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year44.64%
EBIT Next 3Y17.99%
EBIT Next 5YN/A
FCF growth 1Y-33.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.88%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%